iPharmaCenter

Putting patients at center

Telegram
  • Facebook
  • Twitter
  • LinkedIn

  • Home

  • COVID-19

  • News

  • Conferences

  • Healthcare Policies & Systems

  • Regional News

    • North America
    • Europe
    • APAC

  • Patient info

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • TraditionalHealthcare
    • Healthcare Systems
    • News
    • Conferences
    • Know your disease
    • COVID
    • Japan drug approvals
    • USA Pharma News | Healthcare News
    • Europe Pharma News
    • Japan drug approvals
    • Australia Pharma & Healthcare News
    • Canada Pharma and Healthcare News
    • Asia | Pharma | Healthcare News
    • Indication News
    Search
    Drug approvals in Japan | PMDA | MHLW Approvals | News | Media | Japan | iPharmaCenter
    ipharmaservices
    • Sep 28

    Drug approvals in Japan | PMDA | MHLW Approvals | News | Media | Japan | iPharmaCenter

    0
    Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
    ipharmaservices
    • Jan 12, 2021

    Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

    0
    ipharmaservices
    • Sep 26, 2020

    Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA

    0
    AZ received one more approval in Japan, received approval of Imfinzi for SCLC
    ipharmaservices
    • Aug 22, 2020

    AZ received one more approval in Japan, received approval of Imfinzi for SCLC

    0
    JAPAN HEALTHCARE SYSTEM
    ipharmaservices
    • Aug 17, 2020

    JAPAN HEALTHCARE SYSTEM

    0
    ipharmaservices
    • Jul 9, 2020

    Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

    0
    AstraZeneca's Lokelma approved in Japan
    ipharmaservices
    • Mar 29, 2020

    AstraZeneca's Lokelma approved in Japan

    0

    Please feel free to share your thoughts and comments. If you have questions, please comment, and we will try to get back with answers. If you liked the content, please share it on your network.

    For any further updates, contact us at ipharmaservices@gmail.com

    ©2022 by ipharmaservices